Sanli Pharmaceutical: Capitalizing on the Innovation‑Drug Surge in 2026 Shanghai Markets
Explore Sanli Pharmaceutical’s strong alignment with China’s high‑growth innovation‑drug sector and its CRO expertise—positioning for upside amid market rally.
3 minutes to read